Enigma Diagnostics Announces Patent Licence With Applied Biosystems
Enigma Diagnostics Limited announced that it has signed a third licence agreement with Applied Biosystems.
The licence provides Enigma with access to claims of US Patent No. 5,928,907 that describe methods for monitoring nucleic acid amplification in real-time. This is the first such licence Applied Biosystems has granted to the method claims of the '907 patent.
This complements Enigma's existing licence under certain patents owned by Applied Biosystems for real-time PCR thermal cyclers.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.